Professor | Feng Xuebing | Asia Growth Partners

	Upload Avatar (500 x 500)
Name	Feng Xuebing
Contact Information	fengxuebing@1cn.com
Language ability	Chinese, English
Province	Jiangsu

Upload Avatar (500 x 500)

Name

Feng Xuebing

Contact Information

fengxuebing@1cn.com

Language ability

Chinese, English

Province

Jiangsu

University/Lab Affiliation and Title	Nanjing University
Faculty	Medical School
Academic Background & Achievements	1996 - Graduated from Nanjing University Medical School 2000-2003 - PhD in Medicine (Internal Medicine) from Shanghai Second Medical University (now Shanghai Jiao Tong University School of Medicine) 2004-2006 - Postdoctoral research at the University of California, Los Angeles 2010 - Promoted to Chief Physician Received 4 National Natural Science Foundation of China grants Received Jiangsu Province 12th and 13th Five-Year Plan Medical Key Talent Support
Work Experience	1996 - Present - Nanjing University Medical School, Professor and Doctoral Supervisor 2000-2003 - Shanghai Second Medical University, PhD Student 2004-2006 - University of California, Los Angeles, Postdoctoral Researcher

University/Lab Affiliation and Title

Nanjing University

Faculty

Medical School

Academic Background & Achievements

1996 - Graduated from Nanjing University Medical School
2000-2003 - PhD in Medicine (Internal Medicine) from Shanghai Second Medical University (now Shanghai Jiao Tong University School of Medicine)
2004-2006 - Postdoctoral research at the University of California, Los Angeles
2010 - Promoted to Chief Physician
Received 4 National Natural Science Foundation of China grants
Received Jiangsu Province 12th and 13th Five-Year Plan Medical Key Talent Support

Work Experience

1996 - Present - Nanjing University Medical School, Professor and Doctoral Supervisor
2000-2003 - Shanghai Second Medical University, PhD Student
2004-2006 - University of California, Los Angeles, Postdoctoral Researcher

Areas of Focus	Pathogenesis and new diagnostic and therapeutic techniques for autoimmune diseases Precision treatment of autoimmune diseases
Publications	Artesunate inhibits type I interferon-induced production of macrophage migration inhibitory factor in patients with systemic lupus erythematosus, Feng X, Chen W, Xiao L, Gu F, Huang J, Tsao BP, Sun L, 2017 Human umbilical cord mesenchymal stem cells inhibit Tfollicular helper cell expansion through the activation of iNOS in lupus-prone B6.MRL-Faslpr mice, Zhang Z, Feng R, Niu L, Huang S, Deng W, Shi B, Yao G, Chen W, Tang X, Gao X, Feng X, Sun L, 2017 Prognosis for Hospitalized Patients with Systemic Lupus Erythematosus in China: 5-Year Update of the Jiangsu Cohort, Feng X, Pan W, Liu L, Wu M, Ding F, Hu H, Ding X, Wei H, Zou Y, Qian X, Wang M, Wu J, Tao J, Tan J, Da Z, Zhang M, Li J, Sun L; Jiangsu Lupus Collaborative Group, 2016 Identification of interferon-inducible genes as diagnostic biomarker for systemic lupus erythematosus, Feng, X, Huang J, Liu Y, Xiao L, Wang D, Hua B, Tsao BP, Sun L, 2015 Restored immunosuppressive effect of mesenchymal stem cells on B cells after olfactory 1/early B cell factor-associated zinc-finger protein down-regulation in patients with systemic lupus erythematosus, Feng X, Che N, Liu, Y, Chen H, Wang D, Li X, Chen W, Ma X, Hua B, Gao X, Tsao BP，Sun L, 2014 Associations of clinical features and prognosis with age at disease onset in patients with systemic lupus erythematosus, Feng X, Zou Y, Pan W, Wang X, Wu M, Zhang M, Tao J, Zhang Y, Tan K, Li J, Chen Z, Ding X, Qian X, Da Z, Wang M, Sun L, 2014 Inhibition of aberrant circulating Tfh cell proportions by corticosteroids in patients with systemic lupus erythematosus, Feng X, Wang D, Chen J, Lu L, Hua B, Li X, Tsao BP, Sun L, 2012

Areas of Focus

Pathogenesis and new diagnostic and therapeutic techniques for autoimmune diseases
Precision treatment of autoimmune diseases

Publications

Artesunate inhibits type I interferon-induced production of macrophage migration inhibitory factor in patients with systemic lupus erythematosus, Feng X*, Chen W, Xiao L, Gu F, Huang J, Tsao BP, Sun L*, 2017
Human umbilical cord mesenchymal stem cells inhibit Tfollicular helper cell expansion through the activation of iNOS in lupus-prone B6.MRL-Faslpr mice, Zhang Z, Feng R, Niu L, Huang S, Deng W, Shi B, Yao G, Chen W, Tang X, Gao X, Feng X*, Sun L*, 2017
Prognosis for Hospitalized Patients with Systemic Lupus Erythematosus in China: 5-Year Update of the Jiangsu Cohort, Feng X*, Pan W, Liu L, Wu M, Ding F, Hu H, Ding X, Wei H, Zou Y, Qian X, Wang M, Wu J, Tao J, Tan J, Da Z, Zhang M, Li J, Sun L*; Jiangsu Lupus Collaborative Group, 2016
Identification of interferon-inducible genes as diagnostic biomarker for systemic lupus erythematosus, Feng, X*, Huang J, Liu Y, Xiao L, Wang D, Hua B, Tsao BP, Sun L*, 2015
Restored immunosuppressive effect of mesenchymal stem cells on B cells after olfactory 1/early B cell factor-associated zinc-finger protein down-regulation in patients with systemic lupus erythematosus, Feng X*, Che N, Liu, Y, Chen H, Wang D, Li X, Chen W, Ma X, Hua B, Gao X, Tsao BP，Sun L*, 2014
Associations of clinical features and prognosis with age at disease onset in patients with systemic lupus erythematosus, Feng X*, Zou Y, Pan W, Wang X, Wu M, Zhang M, Tao J, Zhang Y, Tan K, Li J, Chen Z, Ding X, Qian X, Da Z, Wang M, Sun L*, 2014
Inhibition of aberrant circulating Tfh cell proportions by corticosteroids in patients with systemic lupus erythematosus, Feng X*, Wang D, Chen J, Lu L, Hua B, Li X, Tsao BP, Sun L*, 2012

Autoimmune Diseases Pathogenesis Diagnostic Techniques Therapeutic Techniques Systemic Lupus Erythematosus Precision Medicine Rheumatology Immunology Clinical Research Biomarkers

Song Han - Wuhan University

Shijun He - University of Chinese Academy of Sciences

Qian Youcun - University of Chinese Academy of Sciences

View All

Personal Information

Academic Information

Research

Contact us

No account yet?

Personal Information

Academic Information

Research

Contact us